Search Results - "Kojima, Yuji"

Preferential crystal growth of germanium by solid phase crystallization¹.

Authors: Kanai, Mikuri Kojima, Yuji Isomura, Masao

Source: Canadian Journal of Physics. Jul2014, Vol. 92 Issue 7/8, p576-581. 6p. 8 Graphs.

Preferential crystal growth of germanium by solid phase crystallization1.

Authors: Kanai, Mikuri Kojima, Yuji Isomura, Masao

Source: Canadian Journal of Physics; Jul2014, Vol. 92 Issue 7/8, p576-581, 6p, 8 Graphs

Preferential crystal growth of germanium by solid phase crystallization¹.

Authors: Kanai, Mikuri Kojima, Yuji Isomura, Masao

Source: Canadian Journal of Physics. Jul2014, Vol. 92 Issue 7/8, p576-581. 6p. 8 Graphs.

Preferential crystal growth of germanium by solid phase crystallization¹.

Authors: Kanai, Mikuri Kojima, Yuji Isomura, Masao

Source: Canadian Journal of Physics. Jul2014, Vol. 92 Issue 7/8, p576-581. 6p. 8 Graphs.

Subjects: Germanium, Crystallization, Thin films, Group 14 elements, Separation (Technology)

Crustal structure of southwest Japan, revealed by the integrated seismic experiment Southwest Japan 2002

Authors: Ito, Tanio Kojima, Yuji Kodaira, Shuichi et al.

Source: Tectonophysics. Jul2009, Vol. 472 Issue 1-4, p124-134. 11p.

Subjects: Continental crust, Structural geology, Physics experiments, Seismology, Cross-sectional method, Cretaceous stratigraphic geology

Geographic Terms: Pacific Coast (Japan), Japan

Design optimization of the 2 K heat exchanger for the superfluid helium cryogenic systems at KEK.

Authors: Kumar, Ashish Nakai, Hirotaka Nakanishi, Kota et al.

Source: Cryogenics; Oct2020, Vol. 111, pN.PAG-N.PAG, 1p

Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group

Authors: Mashiba, Toshie Joko, Kouji Kurosaki, Masayuki et al.

Source: Journal of Viral Hepatitis. Jul2022, Vol. 29 Issue 7, p551-558. 8p.

Real-World Data on Ramucirumab Therapy including Patients Who Experienced Two or More Systemic Treatments: A Multicenter Study.

Authors: Yasui, Yutaka Kurosaki, Masayuki Tsuchiya, Kaoru et al.

Source: Cancers. Jun2022, Vol. 14 Issue 12, p2975-N.PAG. 12p.

Image quality and quantification accuracy dependence on patient body mass in ⁸⁹Zr PET/CT imaging.

Authors: Tateishi, Ukihide Daisaki, Hiromitsu Tsuchiya, Junichi et al.

Source: EJNMMI Physics. 10/30/2021, Vol. 8 Issue 1, p1-11. 11p.

Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score.

Authors: Kaneko, Shun Kurosaki, Masayuki Joko, Kouji et al.

Source: Scientific Reports. 8/3/2020, Vol. 10 Issue 1, p1-9. 9p.

Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains.

Authors: Nakano, Tatsunori Okano, Hiroshi Takahashi, Masaharu et al.

Source: Hepatology Research. Sep2019, Vol. 49 Issue 9, p1003-1014. 12p.

Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.

Authors: Akahane, Takehiro Kurosaki, Masayuki Itakura, Jun et al.

Source: Hepatology Research. Mar2019, Vol. 49 Issue 3, p264-270. 7p.

Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis.

Authors: Fujii, Hideki Kimura, Hiroyuki Kurosaki, Masayuki et al.

Source: Hepatology Research. Aug2018, Vol. 48 Issue 9, p746-756. 11p.

Effect of Mg-doping on the degradation of LiNiO2-based cathode materials by combined spectroscopic methods

Authors: Muto, Shunsuke Tatsumi, Kazuyoshi Kojima, Yuji et al.

Source: Journal of Power Sources. May2012, Vol. 205, p449-455. 7p.

Subjects: Lithium cells, Scanning transmission electron microscopy, Activation energy, Charge transfer, Particles (Nuclear physics)

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.

Authors: Mashiba, Toshie Joko, Kouji Kurosaki, Masayuki et al.

Source: PLoS ONE. 4/16/2018, Vol. 13 Issue 4, p1-13. 13p.

Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus.

Authors: Tamaki, Nobuharu Kurosaki, Masayuki Yasui, Yutaka et al.

Source: Clinical Infectious Diseases. 11/1/2021, Vol. 73 Issue 9, pe3349-e3354. 6p.

Validity of Japanese version of SARC‐F questionnaire in patients with chronic liver disease.

Authors: Ida, Satoshi Kaneko, Ryutaro Murata, Kazuya et al.

Source: Journal of Gastroenterology & Hepatology. May2019, Vol. 34 Issue 5, p947-953. 7p. 5 Charts.

Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.

Authors: Tsuji, Keiji Kurosaki, Masayuki Itakura, Jun et al.

Source: Journal of Gastroenterology. Oct2018, Vol. 53 Issue 10, p1142-1150. 9p. 3 Charts, 4 Graphs.

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study.

Authors: Tsuchiya, Kaoru Kurosaki, Masayuki Sakamoto, Azusa et al.

Source: Cancers. Jun2021, Vol. 13 Issue 11, p2608. 1p.

X-ray generation by inverse Compton scattering at the superconducting RF test facility.

Authors: Shimizu, Hirotaka Akemoto, Mitsuo Arai, Yasuo et al.

Source: Nuclear Instruments & Methods in Physics Research Section A. Feb2015, Vol. 772, p26-33. 8p.